Made advanced cases worse, diluted benefit from milder cases so would need new clinical trial for widespread use
Made advanced cases worse, diluted benefit from milder cases so...
-
- There are more pages in this discussion • 326 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.10M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.3¢ | 21.0¢ | $4.002K | 18.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 123170 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 190333 | 2 |
View Market Depth
| Last trade - 15.09pm 03/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |